Scholars Central

Conference abstractPublished 14 Nov 2016

Longterm follow- up over 1000 consecutive adult patients treated with extracorporeal membrane oxygenation for refractory postcardiotomy cardiogenic shock

Authors: Sven Lehmann

Germany

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Introduction: The aim of the study was to evaluate the clinical outcome, 30 day- and longterm follow up in patients undergoing ECMO for refractory postcardiotomy cardiogenic shock. Methods: We analyzed all patients undergoing ECMO-Therapie (n=1040; age = 55.8±20.8; 67.2% male) between 11/1997 and 12/2013 at our institution. Follow-up range was from 0 to 13.9 years and was complete in 100%. Results: Patient mean body mass index was 26.6±5.4 kg/m², diabetes in 23.6%, pulmonary hypertension in 15.6%, active smoking in 25.1%, chronic obstructive pulmonary disease in 5.8%, peripheral arterial disease in 21.3%, preoperative intravenous inotropic in 9.2%, preoperative dialysis was in 4.6% and ejection fraction of 43.9±18%. Isolated CABG procedure was performed in 21% and isolated valve procedure in 12.2%. 30 day survival rate was 53±1.6%, 5 year survival rate was 19.8±1.5% and 16.4±1.9% after 10 years. Patient who were discharged from hospital had a 5 year survival rate of 60.6%±3.6% and 10 year survival rate of 50.3±5.3%. Additional surgery procedure increased mortality rate significant. Multivariate regression analysis revealed older age (p=0.01; OR 1.01 per year), preoperative beta blocker (p=0.005; OR 1.6) and active smoking (p=0.002; OR 1.7) as independent risk factors for mortality. Cox analysis revealed following predictors for long term mortality: preoperative calcium antagonist (p=0.01; OR 5.9), active smoking (p=0.013; OR 1.8), active endocarditis (p=0.013; OR 1.5), CABG operation (p=0.004; OR 1.3), aortic valve replacement operation (p=0.008; OR 1.3), mitral valve replacement (p=0.005; OR 1.4), replacement of the ascendens aorta (p=0.002; OR 1.5), postoperative cardiac arrhythmia (p=0.005; OR 5.6), symptomatic postoperative transitory psychotic syndrome (p< 0.001; OR 2.4), gastrointestinal complication (p=0.031; OR 8.9). Conclusions: ECMO support is an acceptable option for patients with postcardiotomy cardiogenic shock who otherwise would die and is justified by good long-term outcome of hospital survivors. By high morbidity and mortality and also high resource management ECMO support must be definite by individual risk profile.

Subjects

Cardiology

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • SubjectCardiology
  • BylineArticles whose byline prints “Sven Lehmann”